Collegium Pharmaceutical, Inc. COLL Segment — Commercial expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept coll:CommercialExpenses.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s segment — commercial expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s segment — commercial expenses?
- Collegium Pharmaceutical, Inc. (COLL) reported segment — commercial expenses of $47.36M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s segment — commercial expenses changed year-over-year?
- Collegium Pharmaceutical, Inc.'s segment — commercial expenses increased by 16.1% year-over-year, from $40.79M to $47.36M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — commercial expenses?
- Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s segment — commercial expenses has grown at a 32.9% compound annual growth rate (CAGR), from $68.83M to $161.5M.
- What does segment — commercial expenses mean?
- Encompasses costs related to sales, marketing, and promotional activities required to drive product adoption and maintain market share. These expenditures are critical for assessing the company's investment in commercial growth and customer acquisition.